2014
DOI: 10.1038/jcbfm.2014.178
|View full text |Cite|
|
Sign up to set email alerts
|

Longitudinal Changes in Resting-State Brain Activity in a Capsular Infarct Model

Abstract: Strokes attributable to subcortical infarcts have been increasing recently in elderly patients. To gain insight how this lesion influences the motor outcome and responds to rehabilitative training, we used circumscribed photothrombotic capsular infarct models on 36 Sprague-Dawley rats (24 experimental and 12 sham-operated). We used 2-deoxy-2-[(18)F]-fluoro-D-glucose-micro positron emission tomography (FDG-microPET) to assess longitudinal changes in resting-state brain activity (rs-BA) and daily single-pellet r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
23
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 13 publications
(26 citation statements)
references
References 39 publications
3
23
0
Order By: Relevance
“…We have previously demonstrated that microPET is a useful tool for assessing the longitudinal changes in restingstate brain activity (RSA) in a capsular infarct model. 11 In particular, microPET showed that SPRT training appeared to reduce cortical diaschisis and activate several subcortical structures, which presumably contributed to motor recovery. However, all animals received SPRT training in this previous study, so it was not clear whether these changes were the result of SPRT training, or the natural healing process, or a combination of both.…”
Section: Introductionmentioning
confidence: 98%
“…We have previously demonstrated that microPET is a useful tool for assessing the longitudinal changes in restingstate brain activity (RSA) in a capsular infarct model. 11 In particular, microPET showed that SPRT training appeared to reduce cortical diaschisis and activate several subcortical structures, which presumably contributed to motor recovery. However, all animals received SPRT training in this previous study, so it was not clear whether these changes were the result of SPRT training, or the natural healing process, or a combination of both.…”
Section: Introductionmentioning
confidence: 98%
“…It must also be acknowledged that the motor dysfunction observed following MCAO may not have been solely attributed to loss of CST axons from the ischaemic hemisphere. For instance, the internal capsule has extensive subcortical-cortical connections within the affected hemisphere and between the two hemispheres and lesioning of the internal capsule results in depressed activity of these remote interconnected structures [ 33 ]. Thus, it cannot be ruled out that diaschisis contributed to the motor deficits and that the resolution of diaschisis participated in the functional recovery.…”
Section: Discussionmentioning
confidence: 99%
“…Endothelin-1 (0.2 μg/μL American Peptide, Sunnyvale) was delivered by the Nanolitre injection system (World Precision Instruments, Sarasota, Fl) using a SYS-Micro 4 Controller (World Precision Instruments, Sarasota, Fl). Stereotaxic coordinates of the injection site for MCAo were: anteroposterior, +0.9 mm; mediolateral, −5.2mm; and dorsoventral, −8.6 mm with respect to bregma 25 whereas for SCII were: anteroposterior, −3.0 mm; mediolateral, −3.0 mm; and dorsoventral, −7.0 mm with respect to bregma 1112 . Doses of endothelin-1 were 3 μl for MCAo (240 pMol dissolved in 0.9% sterile saline) and1 μl for capsular injury (80 pMol dissolved in 0.9% sterile saline).…”
Section: Methodsmentioning
confidence: 99%
“…Ischemic damage was induced by injecting the vasoactive peptide endothelin-1 either onto the proximal branches of the middle cerebral artery (MCA) along the lateral aspect of the frontal cortex or into the subcortical territory within and surrounding the internal capsule, as previously described. 11,12,25 The hemisphere contralateral to each animal’s preferred reaching paw was targeted for injury. Animals were anesthetized with ketamine hydrochloride (70 mg/kg, intraperitoneally [ip]) and xylazine (5 mg/kg, ip), with supplemental isofluorane (0.15%) and ketamine (20 mg/kg, ip).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation